JSIAMA Biopharmaceuticals

Nanjing, China · Founded 2021 · Privately Held (backing)

Developer of clinical-stage biopharmaceuticals designed for innovative immunotherapies targeting respiratory diseases, including cancer. JSIAMA Biopharmaceuticals is based in Nanjing, China and was founded in 2021. Its last reported valuation was $66.2 million in Mar 2025. It has raised $6.9 million.

Last reported valuation

$66.2M

Oct 2026

Priced at

—

Total raised

$6.9M

Last round

—

How much has JSIAMA Biopharmaceuticals raised?

$6.9Macross 0 recorded rounds

Free account

More of JSIAMA Biopharmaceuticals with a free account

·Watch JSIAMA Biopharmaceuticals: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

JSIAMA Biopharmaceuticals investors

3 investors are on record for JSIAMA Biopharmaceuticals, including Tailong VC, Prosperico Ventures and Zhejiang Hisun Pharmaceutical Company.

For fundraisers

Raising for a company like JSIAMA Biopharmaceuticals?

3 investors have backed JSIAMA Biopharmaceuticals.

See all 3 investors →

Frequently asked about JSIAMA Biopharmaceuticals

How much has JSIAMA Biopharmaceuticals raised?: JSIAMA Biopharmaceuticals has raised $6.9M in total across 0 recorded funding rounds.